ISDA

Entry Detail

PDB ID:

6ALC

Keywords:

Title:

CREBBP bromodomain in complex with Cpd 4 (1-(1-(cyclopropylmethyl)-3-(1H-indol-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2017-08-07

Release Date:

2018-08-08

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.39 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.19

Space Group:

H 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:CREB-binding protein
Chain IDs:A, B
Chain Length:114
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q92793 Pfam ID:PF00439 EC:2.3.1.48

Ligand Molecules

BKD

DMS

EDO

Primary Citation

Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300.

Lai, K.W, Romero, F.A, Tsui, V, Beresini, M.H, de Leon Boenig, G, Bronner, S.M, Chen, K, Chen, Z, Choo, E.F, Crawford, T.D, Cyr, P, Kaufman, S, Li, Y, Liao, J, Liu, W, Ly, J, Murray, J, Shen, W, Wai, J, Wang, F, Zhu, C, Zhu, X, Magnuson, S.Show

Bioorg. Med. Chem. Lett. 28 15 23 (2018)

PMID: 29169673 DOI: 10.1016/j.bmcl.2017.11.025

Abstact

A novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP, compound 35 (GNE-207), has been identified through SAR investigations focused on optimizing al bicyclic heteroarene to replace the aniline present in the published GNE-272 series. Compound 35 has excellent CBP potency (CBP IC50 = 1 nM, MYC EC50 = 18 nM), a selectively index of >2500-fold against BRD4(1), and exhibits a good pharmacokinetic profile.

Legend

Protein

Chemical

Disease

Primary Citation of related structures